Filter posts

Riding the Bull Market: What’s in Store for Biotech Dealmakers in 2015?

In many ways, 2014 was a record year for biopharma dealmaking, with $355 billion in …

The Next Step: How Companies Build Successful Therapeutic Franchises from the Ground Up

Building a new franchise in a therapeutic from scratch poses a host of challenges, from …

Legislative Best Practices in Support of Bioscience Economic Development

Despite a difficult economic environment the past couple years, states across the country have found …

Business Development and Building the Relationship After BIO

There is a great energy here at BIO, and you can feel it as you …

Pharma R&D Pipeline Value Jumps 18 Percent to $493 Billion

The pharmaceutical industry continues its impressive two-year growth with no signs of slowing down according …

Prepare and Protect from Biological Threats

Yesterday the Alliance for Biosecurity hosted a panel that outlined the important role played by …

Opening Day Recap of BIO 2015: What the Official Bloggers Have to Say

Today, our BIO Official Bloggers, writers who are on top of the biotechnology beat, released …

Welcome to Philadelphia and to BIO 2015!

Over the course of the next few days, you will have the opportunity to hear …

BIO Innovation Zone Company Snapshots: Iron Horse Diagnostics and Nimbic Systems

This week in Philadelphia at the BIO International Convention, BIO is partnering with the National Institutes of …

BIO Innovation Zone Company Snapshots: Aciont Inc. and TF Health Co.

This week in Philadelphia at the BIO International Convention, BIO is partnering with the National Institutes of …